VXRT Vaxart Inc

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.

$3.75  +0.25 (7.14%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/19/2013
Outstanding shares:  126,405,811
Average volume:  2,899,373
Market cap:   $442,420,339
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYWJD92
Valuation   (See tab for details)
PE ratio:   -5.96
PB ratio:   2.84
PS ratio:   939.32
Return on equity:   -47.82%
Net income %:   -16,892.57%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy